Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health

Tidepool, the software nonprofit that collects data from diabetes devices, announces a major new project to drive better research and products from real-world data

Launch by end of 2017 in major pharmacies at lower price than other CGMs; No fingerstick calibration needed, 10-day wear, 12-hour warmup

Research presented at EASD 2017 showcased drugs, both new and old, that improve blood sugar management, weight loss, heart health, and even blood pressure

People with type 1 or type 2 diabetes on intensive insulin therapy can qualify. A major win for the diabetes community following years of patient advocacy!

The diaTribe Foundation and TCOYD host discussion at ADA focusing on access, outcomes beyond A1c, and future expectations

One Drop Premium and Bluetooth-enabled Chrome meter available in US and EU, as well as 24/7 in-app support

What’s new in smart pens and caps for capturing injection doses? Plus, two cool new health apps with built-in artificial intelligence

A new challenge from Amazon and Merck calls for innovative solutions that use Alexa voice technology to help improve diabetes management

Learn from the experts about how best to support teens with diabetes and engage in difficult health and wellbeing conversations

How diabetes educators see people with diabetes differently – research from the American Association of Diabetes Educators conference

Cash-pay strips with good accuracy and co-pay programs to save money

The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr

New Dexcom and Fitbit collaboration to put CGM data on the wrist, a convenience win and the third smartwatch platform for Fitbit. What else might they develop?

Novo Nordisk’s once-weekly injectable GLP-1 for type 2 diabetes recommended for approval, given strong A1c reduction and weight loss

A decision on Novo Nordisk’s faster-acting mealtime insulin is expected in late 2017; also launched in Canada, Germany, and the UK, and coming soon to more European...

With Roche’s support, mySugr will expand to more countries and will even begin offering a new package with unlimited test strips and diabetes coaching through German...

The U.S. Food and Drug Administration (FDA) has approved the once-weekly injectable Ozempic (semaglutide) for use in type 2 diabetes.

Medtronic hopes to launch at least 10 products over the next two years: new CGM and apps, 670G pump with Bluetooth, AI, and more!

Available for BCBS members in South Carolina and Arkansas, with Georgia coming soon; program includes an app, coaching, a connected meter, and unlimited supplies at no...